17-21198839-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003876.3(TMEM11):c.64G>T(p.Val22Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000209 in 1,606,172 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003876.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM11 | NM_003876.3 | c.64G>T | p.Val22Leu | missense_variant, splice_region_variant | 2/2 | ENST00000317635.6 | NP_003867.1 | |
TMEM11 | NR_024547.2 | n.365G>T | splice_region_variant, non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM11 | ENST00000317635.6 | c.64G>T | p.Val22Leu | missense_variant, splice_region_variant | 2/2 | 1 | NM_003876.3 | ENSP00000319992 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000171 AC: 42AN: 245874Hom.: 0 AF XY: 0.000203 AC XY: 27AN XY: 133062
GnomAD4 exome AF: 0.000208 AC: 303AN: 1453948Hom.: 1 Cov.: 31 AF XY: 0.000191 AC XY: 138AN XY: 722066
GnomAD4 genome AF: 0.000217 AC: 33AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2021 | The c.64G>T (p.V22L) alteration is located in exon 2 (coding exon 2) of the TMEM11 gene. This alteration results from a G to T substitution at nucleotide position 64, causing the valine (V) at amino acid position 22 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at